Innovative Cancer Screenings Offered Through The Iowa Clinic’s Executive Health Program

The Iowa Cancer Registry released a report in March indicating the state of Iowa is projected to have the second highest incidence rate of cancer cases in the country this year. 

Early detection is key when it comes to bending the cancer mortality curve. In fact, cancers diagnosed in early stages have a 4x higher survival rate over 5 years than cancers diagnosed in later stages.

Physicians currently have access to only a handful of preventative cancer screenings that only detect five kinds of cancer. The Iowa Clinic is excited to be the first healthcare group to offer the Galleri® test, a new innovative multi-cancer early detection test, in Iowa as part of our Executive Health program. 

The Galleri test works by analyzing methylation patterns of cell-free DNA in the bloodstream, using next-generation sequencing and machine learning algorithms. The test screens for a cancer signal and predicts the tissue type or organ associated with the signal. These signals are indicative of 50+ cancers, including fast-spreading, aggressive cancers that don’t show symptoms in early stages, such as pancreatic and ovarian.

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test is intended to detect cancer signal and predict where in the body the cancer signal is located. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. 

The executive health program at The Iowa Clinic helps business leaders carve time out of their busy schedules to prioritize healthcare. An investment in your health is like an investment in your business. It pays off now and for years to come. Call 515.875.9855 to request an appointment or access more information at www.iowaclinic.com/executivehealth.